Curr Med 3 , 14 (2024)
J Physiol Pharmacol 65(3):349357 Cui X, Zhao X, Wang Y, Yang Y, Zhang H (2020) Glucagonlike peptide1 analogue exendin4 modulates serotonin transporter expression in intestinal epithelial cells
Semaglutide, by contrast, stimulates the GLP-1 receptor to slow stomach emptying, increase insulin secretion, and reduce appetite
By acting on the brain's appetite centers, Semaglutide suppresses hunger, controls cravings, and ultimately helps individuals reduce their food intake
In February 2026, the FDA approved Ozempic as the new proprietary name for the 1.5-mg, 4-mg and 9-mg oral semaglutide formulations for adults with T2DM
Thats where protein and strength training come in